| __timestamp | BioMarin Pharmaceutical Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 60987000 |
| Thursday, January 1, 2015 | 152008000 | 125542000 |
| Friday, January 1, 2016 | 209620000 | 210460000 |
| Sunday, January 1, 2017 | 241786000 | 275119000 |
| Monday, January 1, 2018 | 315264000 | 409539000 |
| Tuesday, January 1, 2019 | 359466000 | 547758000 |
| Wednesday, January 1, 2020 | 524272000 | 736300000 |
| Friday, January 1, 2021 | 470515000 | 904200000 |
| Saturday, January 1, 2022 | 483669000 | 1080300000 |
| Sunday, January 1, 2023 | 577065000 | 1262200000 |
| Monday, January 1, 2024 | 1530500000 |
In pursuit of knowledge
In the ever-evolving landscape of biopharmaceuticals, understanding cost dynamics is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and BioMarin Pharmaceutical Inc. have showcased intriguing trends in their cost of revenue. From 2014 to 2023, Vertex Pharmaceuticals saw a staggering increase of over 1,900% in its cost of revenue, peaking at approximately $1.26 billion in 2023. In contrast, BioMarin's cost of revenue grew by about 345% during the same period, reaching around $577 million.
This data highlights Vertex's aggressive expansion strategy, possibly driven by its focus on innovative treatments. Meanwhile, BioMarin's steadier growth reflects its commitment to niche markets. These trends underscore the diverse strategies employed by leading biopharmaceutical companies to navigate the competitive landscape. As the industry continues to evolve, monitoring these financial metrics will be key to understanding future market dynamics.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs Grifols, S.A.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Viridian Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.
Cost of Revenue: Key Insights for BioMarin Pharmaceutical Inc. and Xencor, Inc.